iThriveMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: compounded GLP-1 within a lab-driven longevity and hormone clinic
iThriveMD scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
iThriveMD is a longevity and metabolic-health clinic (physical locations plus telehealth) offering compounded GLP-1 weight loss — semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs — alongside hormone therapy (HRT/TRT), NAD+, peptides, IV therapy, sexual health, and diagnostic lab testing. Care is lab-driven with personalized protocols and a free initial consultation; lower 'preferred pricing' is available to members. It publishes a thorough legal/policy suite. The compounding pharmacy is not named and no LegitScript certification is shown.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to iThriveMD
Editorial score · methodology
TMates
Best for: nationwide compounded GLP-1 availability including Puerto Rico
Editorial score · methodology
Editorial score · methodology
iThriveMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Microdosing tirzepatide
- Starting price
- $299/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored iThriveMD
Each dimension is scored algorithmically from iThriveMD’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.0/10At $299/mo, iThriveMD runs about 76% above the $170 median for GLP-1 providers.
Effectiveness25%
8.6/10iThriveMD offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.9/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.8/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.6/10iThriveMD's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.4/10iThriveMD provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this iThriveMD review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $299–$399/mo across 2 dose/plan tiers — checked August 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with iThriveMD
We walked iThriveMD’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Book a free initial consultation online (telehealth available in California and Arizona).
- 2Complete in-depth diagnostic testing and baseline labs before any plan begins.
- 3A provider creates a personalized GLP-1 weight-loss protocol.
- 4Ongoing adjustments are made at follow-up check-ins.
- Weight-loss plan pricing shown upfront: $195/mo listed at $146.25/mo with a discount applied.
- Explicitly requires baseline labs and diagnostic testing before starting a plan.
- Promotes a 90-day promotion offering up to 76% off member add-ons.
- Service limited to California and Arizona.
- Initial consultation advertised as free.
iThriveMD customer support
- Phone
- 619-612-0672
GLP-1 medications iThriveMD offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides iThriveMD offers
Beyond GLP-1s, iThriveMD also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check iThriveMD's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs
- Lab testing and personalized protocols with a medical team; free initial consultation
- Very thorough legal/policy suite (Terms, Privacy, EUA, Shipping, Returns, CCPA)
- Broad longevity menu: hormones (HRT/TRT), NAD+, peptides, IV therapy, sexual health, diagnostics
Watch-outs
- Premium pricing — higher than budget compounded-GLP-1 competitors (lowest rates need 'preferred pricing')
- Headline GLP-1 pricing is 'starting at'; full cost depends on dose and program length
- Compounding pharmacy partner not named
- Not LegitScript-certified (no certification displayed)
Is iThriveMD worth it?
What iThriveMD is selling, in one line, is compounded GLP-1 within a lab-driven longevity and hormone clinic. It runs $299/month — a premium versus the rest of the category, so its specific extras need to earn that difference. It's a fairly plain, no-frills entry in the glp-1 providers category, without a lot of extra add-ons layered on top of the medication itself.
It offers a microdosing option. It also includes lab testing and offers NAD+ or peptide add-ons.
How much iThriveMD actually costs
Compounded semaglutide runs $299/month and compounded tirzepatide runs $399/month.
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month. iThriveMD's standing rate sits at the premium end of that range, well above the cheapest options in the category.
For a direct comparison, Maximus runs semaglutide and tirzepatide from $249.99/month — worth pricing against iThriveMD before you commit.
Medications: what iThriveMD prescribes
iThriveMD prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who iThriveMD is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program without a lot of extra features to evaluate.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
iThriveMD costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, MangoRx is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
iThriveMD scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with iThriveMD?
Starting at $299/month. See current pricing and start your free consultation.
iThriveMD might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider TMates.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this iThriveMD review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See iThriveMD's current pricing
Plans start at $299/month. Start your free consultation to check eligibility and today's price.